| 产品名称： | Aspergillus niger van Tieghem |
|---|---|
| 商品货号： | TS195749 |
| Deposited As： | Aspergillus niger van Tieghem, anamorph |
| Strain Designations： | 350(-)52 350-52, argB (350-52) |
| Application： | transformation host |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Comments： | Mutant derived from ATCC 46951. Defective in ornithine transcarbamylase function |
| Medium： | ATCC® Medium 324: Malt extract agar |
| Growth Conditions： | Temperature: 24.0°C |
| Name of Depositor： | Allelix Biopharmaceuticals, Inc. |
| U.S. Patent Number： | |
| Isolation： | Mutant derived from ATCC 46951 |
| References： | Buxton FP, et al. Aspergillus niger transformation system. US Patent 4,885,249 dated Dec 5 1989 Buxton FP, et al. Transformation of Aspergillus niger using the argB gene of Aspergillus nidulans. Gene 37: 207-214, 1985. PubMed: 3902571 Ozeki K, et al. Transformation of intact Aspergillus niger by electroporation. Biosci. Biotechnol. Biochem. 58: 2224-2227, 1994. PubMed: 7765715 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Aspergillus niger van Tieghem |
|---|---|
| 商品货号： | TS195749 |
| Deposited As： | Aspergillus niger van Tieghem, anamorph |
| Strain Designations： | 350(-)52 350-52, argB (350-52) |
| Application： | transformation host |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Comments： | Mutant derived from ATCC 46951. Defective in ornithine transcarbamylase function |
| Medium： | ATCC® Medium 324: Malt extract agar |
| Growth Conditions： | Temperature: 24.0°C |
| Name of Depositor： | Allelix Biopharmaceuticals, Inc. |
| U.S. Patent Number： | |
| Isolation： | Mutant derived from ATCC 46951 |
| References： | Buxton FP, et al. Aspergillus niger transformation system. US Patent 4,885,249 dated Dec 5 1989 Buxton FP, et al. Transformation of Aspergillus niger using the argB gene of Aspergillus nidulans. Gene 37: 207-214, 1985. PubMed: 3902571 Ozeki K, et al. Transformation of intact Aspergillus niger by electroporation. Biosci. Biotechnol. Biochem. 58: 2224-2227, 1994. PubMed: 7765715 |
